Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Phase 1
Recruiting
- Conditions
- CancerSquamous Cell Carcinoma of the Head and NeckNon Small Cell Lung CancerRenal Cell CarcinomaMSI-HighSolid TumorCarcinomaMelanomaTriple-negative Breast Cancer
- Interventions
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Simcha IL-18, Inc.
- Target Recruit Count
- 316
- Registration Number
- NCT04787042
- Locations
- 🇺🇸
HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath